楼主: ribosome
529 1

[兼并重组与公司治理] Creating a Global BioPharma Leader [推广有奖]

  • 4关注
  • 1粉丝

已卖:1038份资源

讲师

8%

还不是VIP/贵宾

-

威望
0
论坛币
2345 个
通用积分
37.1089
学术水平
0 点
热心指数
0 点
信用等级
0 点
经验
8644 点
帖子
154
精华
0
在线时间
408 小时
注册时间
2007-10-28
最后登录
2024-9-25

楼主
ribosome 发表于 2019-1-17 13:33:08 |AI写论文

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
In connection with the proposed transaction between Bristol-Myers Squibb Company (“Bristol-Myers Squibb”) and Celgene Corporation (“Celgene”), BristolMyers Squibb and Celgene will file relevant materials with the Securities and Exchange Commission (the “SEC”), including a Bristol-Myers Squibb registration statement on Form S-4 that will include a joint proxy statement of Bristol-Myers Squibb and Celgene that also constitutes a prospectus of Bristol-Myers Squibb, and a definitive joint proxy statement/prospectus will be mailed to stockholders of Bristol-Myers Squibb and Celgene.
截图.PNG Creating a Global BioPharma Leader INVESTOR PRESENTATION 201901.PDF (1.6 MB, 需要: 3 个论坛币)





二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:Creating Leader eating Global lobal

沙发
edmcheng(未真实交易用户) 发表于 2019-1-17 13:43:42
Thanks a lot!

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
jg-xs1
拉您进交流群
GMT+8, 2026-1-8 10:16